Cancer Cure

The Indian Cancer Society - Cancer Cure Fund is a flagship project of ICS which provides financial aid for treatment to underprivileged cancer patients. Many cancers are curable, if detected early and treated in time. However, many cancer patients in India are not able to afford the treatment costs and therefore do not survive this disease. This project has transformed the lives of over 7300 cancer patients across the country, many of whom have completed their treatment and returned to productive life once again. ICS has implemented this program through 17 empanelled hospitals at a pan India level sanctioning about Rs 196 crores as of March 2019.

As per the data last analyzed in March 2019, 70% of the beneficiaries are less than 30 years of age.

This project is a unique, first of its kind initiative of ICS in collaboration with HDFC AMC Ltd. In February 2011, HDFC AMC launched a debt mutual fund which gave the investors an option to donate 50% or 100% of their dividend income to Indian Cancer Society to fund the treatment cost for cancer patients. ICS is grateful to each of the 5000 investors who have donated their income to ICS and have helped transform the lives of these patients through the Cancer Cure Fund Project. ICS would also like to place on record its gratitude to HDFC AMC for launching this unique product that has enabled ICS to raise the funds required for this project.

HDFC AMC Ltd
Patient's eligibility criteria:
  • Family income not exceeding Rs. 4 lakhs per annum
  • Projected survival rate 50% for adult patients and 70% for paediatric patients
  • Patients in general category (no private or semi-private)
Sanction criteria:
  • Minimum sanction limit Rs. 50,000 to maximum Rs. 5 lakhs
  • For bone marrow treatment, maximum sanction limit of Rs. 8 lakhs

Treatment protocol covered:
  • Chemotherapy
  • Radiation
  • Surgery
  • Supportive care
  • Prosthesis
  • Growth hormone

List of Empanelled Hospitals

Empanelment Yr. Hospital Name State / U.T. Address Telephones
2011 Tata Memorial Hospital Maharashtra Parel, Mumbai, Maharashtra - 400 012 022-24177000
Regional Cancer Centre Kerala Medical College Campus,
Post. Bag No: 2417,
Thiruvananthapurambr, Kerala - 695 011
0471 244 2541
2012 Christian Medical College (CMC) Tamil Nadu Vellore
Tamil Nadu - 632 004
0416 2283350 / 5213350
Cancer Institute (CI) Tamil Nadu Adyar, Chennai,
Tamil Nadu - 600 020
044 24911526
GCRI - Gujarat Cancer Research Institute Gujarat Civil Campus, Asawra,
Ahmedabad, Gujarat - 380 016
079 2268 8000
Rajiv Gandhi Cancer Institute & Research Center Delhi Sector 5, Rohini,
Delhi - 110 085
011 4582 2222
Sher i Kashmir Institute of Medical Sciences J &K Post Bag No. 27,
Soura, Srinagar,
Jammu & Kashmir - 190 011
0194 240 1013
2013 Sawai Man Singh Hospital, Birla Cancer Center Rajasthan C-70, Ram Marg,
Tilak Nagar, Jaipur,
Rajasthan 302 004
0141-2560291 / 2518203
2014 BKL Walawalkar Hospital Maharashtra Shreekshetra Dervan,
Chiplun, Ratnagiri,
Maharashtra - 415 606
02355-264137 / 264149
2015 Basavatarakam Indo American Cancer Hospital Telangana Road No 10, Banjara Hills,
Telangana 500 034
040 2355 1235
Kailash Cancer Hospital Gujarat Muni Seva Ashram, 12-Blue Chip Complex,
Near Rajshree Cinema, Opp Vakal Seva Kendra,
Sayajigunj, Vadodara, Gujarat - 391 760
02668 265 300
Mazumdar Shaw Cancer Center Karnataka 258/A, Bammasandra Industrial Area,
nekal, Thaluk Bengaluru,
Karnataka - 560 099
080- 2783 5222
Patel Hospital Punjab Civil Lines,
Jalandar, Punjab - 144 001
0181-2041000 / 3041000
Mahavir Cancer Sanstha and Research Center Bihar Phulwarisharif,
Patna - 801 505
0612 - 2250127, 7091490890
2016 Cachar Cancer Hospital & Research Center Assam Meherpur,
Assam, Silchar - 788 015
03842-240608
2017 Sri Shankara Cancer Hospital & Research Center Karnataka 1st Cross, Shankara Matt Premises,
Shankarapuram, Basavanagudi,
Bengaluru, Karnataka - 560 004
080 2698 1000
2019 Health Care Group (HCG) Hospital Andhra Pradesh Ongole : Rs No 186/1,
next to Govt ITI College,
Mukthinutala Padu Rural Prakasham District,
Ongole Andhra Pradesh - 532 001
Vijayawada : #44-1-1/3, Padavala, Revu,
Vijayawada, Andhra Pradesh - 520 001
Vishakhapatnam : Pilot # 10,11,12,
survey 13P, Health City Chinnagadili,
Vishakhapatnam - 530 040
0866 243 5900
Due Diligence Team (DDT)

Mumbai & Navi Mumbai

  • Dr. Tushar Vora
    Dr. Tushar Vora
  • Dr. Hasmukh Jain
    Dr. Hasmukh Jain
  • Dr. Shripad Banavali
    Dr. Shripad Banavali
  • Dr. Ashish Gulia
    Dr. Ashish Gulia
  • Dr. Nehal Khanna
    Dr. Nehal Khanna
  • Dr. Shiva Kumar
    Dr. Shiva Kumar
  • Dr. Amit Joshi
    Dr. Amit Joshi
  • Dr. Seema Gulia
    Dr. Seema Gulia
  • Dr. Purna Kurkure
    Dr. Purna Kurkure
  • Dr. Anant Gokarn
    Dr. Anant Gokarn
  • Dr. Manish Bhandare
    Dr. Manish Bhandare
  • Dr. Shraddha Patkar
    Dr. Shraddha Patkar
  • Dr. Kumar Prabhash
    Dr. Kumar Prabhash
  • Dr. Sachin Punatar
    Dr. Sachin Punatar

Bangalore

  • Dr. Hari Menon
    Dr. Hari Menon
  • Dr. Kumaraswamy
    Dr. Kumaraswamy
  • Dr. Ravi Thippeswamy
    Dr. Ravi Thippeswamy
  • Dr. Shekhar Patil
    Dr. Shekhar Patil
  • Dr. Vijay Agarwal
    Dr. Vijay Agarwal
  • Dr. Vikram Kekatpure
    Dr. Vikram Kekatpure
  • Dr. Vishal Rao
    Dr. Vishal Rao
  • Dr. Niti Raizada
    Dr. Niti Raizada
  • Dr. Lohith Reddy
    Dr. Lohith Reddy
  • Dr. N Aditya Murali
    Dr. N Aditya Murali
  • Dr. Vikram Mahiya
    Dr. Vikram Mahiya
Governing Advisory Council (GAC)
  • Mrs. Usha Thorat
  • Mr. M K Sharma
  • Mr. Homi Khusrokhan
  • Dr. Rajendra Badwe
  • Mr. Milind Barve
  • Mr. Naveen Kshatriya
  • Mr. Uday Khanna
  • Mr. Hari L Mundra
  • Dr. Anita Borges
  • Dr. Tapan Saikia
  • Mr. Ramesh Swaminathan
  • Vijayalaxmi Iyyer
  • Dr. Pankaj Chaturvedi
  • Dr. C S Pramesh
  • Dr. S Banavali

Our Stakeholders Speak

  • Dr S Banavali

    With the newer modalities of treatment, the outcome of many non-metastatic cancers has now improved and we can expect more than half of these patients to survive. However, this improved outcome comes at a cost which is beyond the reach of many patients in India. Because of timely help from ICS CCF, thousands of patients across India could undergo treatment with dignity and are now cured of their disease. Thank you, ICS, for making this possible.

    Dr S Banavali, MD, Director, Academics & Prof, Head Medical Oncology - Tata Memorial Centre, Mumbai

  • Dr Tushar Vora

    The evolution of CCF into a sustainable and successful source of financial help for cancer patients from all over the country is exemplary. The partnership between the treating hospitals and the funding sources works on the principles of trust and due diligence. With the potential of a tremendous impact on the healthcare sector of India, consolidation and expansion of the scheme is extremely essential.

    Dr Tushar Vora, MD (Pediatrics), Prof Medical Oncology, Tata Memorial Centre, Mumbai

  • Dr Ravi Kannan

    It is a pleasure to work with ICS CC. In a remote place like Cachar, our efforts to treat cancer patients is made worth the while on account of the support we get from ICS. The team at ICS is committed and makes us feel part of a much larger mission. They often nudge us to apply for more patients, submit reports on time, submit our claims and utilisation reports on time....all without any harassment or offence....purely to ensure that help reaches as many patients as possible. Cachar Hospital, Assam along wtih ICS has supported around 155 cancer patients so far.

    Dr Ravi Kannan, Director Cachar Cancer Hospital and Research Centre, Assam

  • Dr Sunil Khetrapal

    Our hospital has been associated with ICS CCF for the last five years. This is a very useful scheme in favour of underprivileged patients (particularly pediatrics) undergoing treatment for various types of cancers.

    We have been working jointly with ICS to be able to support about 150 children with cancer and many of these patients have completed their treatment and are leading normal lives. The sympathetic help by ICS for needy cancer patients is noteworthy and is much appreciated by us.

    Dr Sunil Khetrapal, COO & MS Rajiv Gandhi Cancer Institute New Delhi

  • Dr. Devi Shetty

    I am very excited to work with Indian Cancer Society to scale up the operations and reach out to millions of deserving patients. We have to look at how to downstage cancer by detecting it early using technology. Technology is the best way to reduce the cost and reach out to millions. Look forward to work with you and make this world a better place to live in."

    Dr. Devi Shetty, Chairman and Founder Mazumdar Shaw Cancer Centre - Bangalore

  • Dr. V.Shanta

    Cancer Institute (W.I.A) Chennai, is privileged to be associated with Indian Cancer Society (ICS). Over the last 6 decades we have strived hard to provide the state of art treatment to the underprivileged without any social or economic divide. This has been made easier by the generosity of ICS whose funding has helped us to fulfill the needs of many patients. Over the last 3 years, the financial assistance from ICS is Rs.2.7 Crores which has supported 120 patients. This funding has been used for providing bone marrow transplantation, limb salvage surgery, many major surgeries, radiotherapy and chemotherapy.

    The unique feature of the funding from ICS is the promptness with which the funds are released. This has helped us in treating patients without delay. We are proud to say that we have not refused “state of art treatment” to any of the patients who have come seeking help.

    Dr. V.Shanta, Chairman Cancer Institute, Adyar

  • Dr. Raju Titus Chacko

    The Christian Medical College, Vellore has been striving to provide excellent, affordable care to patients who come from all over the country. Patients who come from the poorer and vulnerable strata of society are preferentially afforded the best possible treatment. Partnering with the Indian Cancer Society in providing funding for curable cancers has tremendously increased the number of such patients receiving treatment. They go home with a satisfied smile and much gratitude, knowing that they have beaten the dreaded disease and have been looked after in the best way possible. Thank you ICS and all your donor funding partners for boosting our ability to deliver such treatments.

    Dr. Raju Titus Chacko, Professor Medical Oncology, Christian Medical College, Vellore

  • Dr (Prof) R A Badwe

    Indian Cancer Society’s Cancer Cure Fund is one of the most innovative ideas to help & support cancer patients in India. It will not be an exaggeration, if I say this is quite innovative globally, that investors would put in funds and this fund will be utilized for poor patients and they would get some tax benefits out of that. What is unique about this fund is that it has a shortest turnaround time. Unless the funds are available the treatment cannot begin and these funds are immediately made available by Indian Cancer Society’s Cancer Cure Fund. This has reduced abandonment of treatment by more than 50% of patients.

    Dr (Prof) R A Badwe (Hospital Partner) Director, Tata Memorial Hospital, Mumbai

  • It is indeed a great initiative. This kind of ventures would surely bring smile on the faces of many cancer patients, who found it difficult to meet their ends. RCC, Trivandrum is glad to be a part of this and hope that this venture may inspire more and more people to extend their help and support to the poor and needy cancer patients.

    May God torrentially shower all the blessings on all of you who are a part of this great initiative.

    Dr P T Latha Assoc Professor & Welfare Officer - Regional Cancer Centre, Trivandrum

Arun Kurkure Initiation & Treatment Fund

(AKITF)

AKITF project was launched in April 2014 by Indian Cancer Society. Its objective is to support underprivileged cancer patients towards initial diagnosis tests and funding for emergency treatment without any loss of time. The project was introduced to reduce the drop rate of patients who are not undergoing tests or not initiating treatment due to affordability.

AKITF Project was re-launched on 4th Feb 2019 at ICS empanelled hospitals

  • Cachar Cancer Hospital and Research Centre, Silchar, Assam
  • BKL Walawalkar Hospital, Chiplun, Maharashtra
Cachar Cancer Hospital and Research Centre, Silchar, Assam
BKL Walawalkar Hospital, Chiplun, Maharashtra

Maximum of Rs 25,000/- per patient will be sanctioned for initial diagnosis & initial treatment.

Patient eligibility criteria
  • Only for Indian citizens
  • No discrimination on account of age, sex or religion
  • Funding to be done only if patient is treated at ICS empanelled hospital.
  • The patient must be registered as a general ward patient (not private or semiprivate).
  • Criteria for selecting patient - family income not exceeding Rs. 4 lakhs per annum.
  • Additional eligibility criteria for initial treatment: Initial treatment will be applicable only for cancer diagnosed patients.

Documentation from patient
  • Aadhar card of the patient (if paediatric patient then Aadhar card of the one of the parents)
  • Income proof that patient’s family income is not exceeding Rs. 4 lakhs per annum.
  • Registration page confirming patient belonging to general category of the empanelled hospital
  • Prescription of the treating doctor for initial diagnosis
  • Cost certificate for initial treatment from the treating doctor
  • Additional documents for initial treatment: All cancer reviewed and attached to the documentation by the hospital